"Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs" [1]
"FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny."
